The Journal of Prevention of Alzheimer’s Disease has shortly ago released an article evaluating the safety and efficacy of HMTM in participants with mild cognitive impairment (MCI). Please see below for the full published article:
New Paper on HTMN – The Anti Tau Drug – Released